New UK Clinical Trial for Post-Prostatectomy Recovery

29.05.2026 - Vertica® experts

Vertica Launches New UK Clinical Trial for Post-Prostatectomy Recovery

Vertica is pleased to announce the initiation of a new clinical trial in the United Kingdom evaluating the role of the Vertica® device in post-prostatectomy rehabilitation.

Conducted in collaboration with St. Peter’s Andrology at King Edward VII Hospital in London, this prospective study is led by Associate Professor Wai Gin (Don) Lee. The trial will investigate the impact of integrating Vertica’s non-invasive radiofrequency (RF) therapy into early rehabilitation protocols following prostatectomy, with the goal of improving long-term functional outcomes for patients.

This study represents an important milestone in the continued expansion of the clinical evidence supporting innovative, non-invasive therapeutic solutions for men’s health and post-surgical recovery. The findings are expected to contribute valuable insights into optimizing rehabilitation pathways and enhancing patient outcomes after prostate cancer surgery.

For more information about the study and the latest company updates, please read the full announcement here.

Accessibility